ERcast: Clinical Perspectives Podcast Preview
The summary below is from an episode of ERcast: Clinical Perspectives
Poisoning resuscitations hinge on recognizing the toxin-specific physiology behind shock, dysrhythmia, and respiratory failure. The 2023 AHA focused update sharpens emergency management for opioid, benzodiazepine, beta-blocker, calcium channel blocker, cyanide, digoxin, local anesthetic, organophosphate, cocaine, methemoglobinemia, and sodium-channel blocker poisoning.
Airway and antidote priorities
- Opioid arrest priorities: In suspected opioid overdose with cardiac arrest, high-quality CPR and ventilation come before naloxone; if there is a pulse with inadequate breathing, naloxone is reasonable.
- Post naloxone observation: Recurrent opioid toxicity is common after an initial response, so patients need monitored observation until breathing, mental status, and vital signs have normalized.
- Selective flumazenil use: Flumazenil belongs only in carefully selected pure benzodiazepine poisoning; seizure history and benzodiazepine or alcohol dependence are major reasons to avoid it.
- Naloxone before flumazenil: When opioid and benzodiazepine co-ingestion is possible, naloxone is the first antidote for respiratory depression. We get into the practical sequencing in the episode.
Cardiotoxic overdose management
- High dose insulin backbone: For beta-blocker and calcium channel blocker poisoning with hypotension, high-dose insulin is a first-line therapy alongside vasopressors rather than a late salvage move.
- Glucagon's narrower role: Glucagon remains reasonable for beta-blocker poisoning with bradycardia or hypotension, but its benefit in calcium channel blocker toxicity is much less certain.
- Lipid emulsion boundaries: IV lipid emulsion is not routinely recommended for beta-blocker or calcium channel blocker poisoning, but it remains indicated for local anesthetic systemic toxicity.
- ECMO rescue threshold: VA-ECMO has a defined role in refractory cardiogenic shock from beta-blocker, calcium channel blocker, local anesthetic, and sodium-channel blocker poisoning. We cover where that escalation fits on the show.
- Dialyzable exceptions: Hemodialysis may help in severe atenolol or sotalol poisoning, a useful reminder that not all beta-blocker overdoses behave the same way.
Sodium channel blockade syndromes
- Bicarbonate first line: Sodium bicarbonate is the cornerstone therapy for life-threatening cardiotoxicity from tricyclic antidepressants and other sodium-channel blocker poisonings.
- Cocaine wide complex treatment: In cocaine poisoning with wide-complex tachycardia, sodium bicarbonate is reasonable and lidocaine is also supported, reflecting sodium-channel toxicity rather than simple stimulant excess.
- Local anesthetic dysrhythmias: Local anesthetic systemic toxicity with wide-complex tachycardia also responds to sodium bicarbonate, while seizures should be treated with benzodiazepines.
- Lipid as rescue: For sodium-channel blocker poisoning, lipid emulsion is a rescue therapy after standard measures fail rather than an early routine antidote. We walk through that distinction in the chapter.
Subscribe to ERcast: Clinical Perspectives to listen to the episode.
References:
- Lavonas EJ, Akpunonu PD, Arens AM, et al. 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2023;148(16):e149-e184. PMID: 37721023
Faculty
- Drew Kalnow, DO
Dr. Drew Kalnow is an emergency medicine physician and educator based in Columbus, Ohio. He completed his emergency medicine training at OhioHealth Doctors Hospital Emergency Medicine Residency. Dr. Kalnow is passionate about advancing emergency medicine through high-quality education, with a particular focus on simulation, learning theory, and innovative teaching.
- Andy Little, DO
Dr. Andy Little is an emergency medicine physician and educator. He earned his medical degree from the Ohio University Heritage College of Osteopathic Medicine and completed his emergency medicine residency at OhioHealth Doctors Hospital Emergency Medicine Residency, where he served as Chief Resident. He has received multiple national awards, including recognition from the American Osteopathic Association, American College of Osteopathic Emergency Physicians, and Emergency Medicine Residents' Association.